Gregory Gene Freitag Insider Profile

4 Followers
Gregory Gene Freitag, Director at AxoGen, holds 283.50K shares in AxoGen (Ticker: AXGN), holds 46.15K shares in PDS Biotechnology (Ticker: PDSB), holds ― shares in ZyVersa Therapeutics (Ticker: ZVSA).
tipranks
Gregory Gene Freitag

Gregory Gene Freitag
AxoGen (AXGN)
Director

Ranked #48,883 out of 99,218 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

0.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
95.94%
4.06%
0.00%
0.00%
A breakdown of Gregory Gene Freitag's holdings

Insider Roles

AxoGen
(AXGN)
Director
PDS Biotechnology
(PDSB)
Director
ZyVersa Therapeutics
(ZVSA)
Director
Pressure Biosciences
(PBIO)
Director
Roles that Gregory Gene Freitag holds in companies

Most Profitable Insider Trade

Stock:
AxoGen
(AXGN)
Rating:Informative Sell
Date:Nov 15, 2018 - Nov 15, 2019
Return:+50.80%
The most profitable trade made by Gregory Gene Freitag

Gregory Gene Freitag's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AxoGen
Jun 06, 2024
Director
Uninformative Buy
81.66K
$3.59M
PDS Biotechnology
Jun 17, 2021
Director
Informative Buy
50.00K
$151.84K
ZyVersa Therapeutics
Director
Pressure Biosciences
Apr 10, 2012
Director
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Gregory Gene Freitag's performance on stock

Gregory Gene Freitag insider profile FAQ

What is the percentage of profitable transactions made by Gregory Gene Freitag?
The percentage of profitable transactions made by Gregory Gene Freitag is 67%.
    What is the average return per transaction made by Gregory Gene Freitag?
    The average return per transaction made by Gregory Gene Freitag is 0.00%.
      What stocks does Gregory Gene Freitag hold?
      Gregory Gene Freitag holds: AXGN, PDSB, ZVSA, PBIO stocks.
        What was Gregory Gene Freitag’s latest transaction?
        Gregory Gene Freitag latest transaction was an Uninformative Buy of $81.66K.
          What was Gregory Gene Freitag's most profitable transaction?
          Gregory Gene Freitag’s most profitable transaction was an Informative Sell of AXGN stock on November 15, 2018. The return on the trade was 50.80%.
            What is Gregory Gene Freitag's role in AxoGen?
            Gregory Gene Freitag's role in AxoGen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.